Etretinate is a second-generation synthetic aromatic retinoid used in the treatment of severe psoriasis by modulating keratinocyte differentiation to inhibit abnormal skin cell proliferation and inflammation.… Read more
Etretinate is a second-generation synthetic aromatic retinoid used in the treatment of severe psoriasis by modulating keratinocyte differentiation to inhibit abnormal skin cell proliferation and inflammation. The pharmaceutical compounds listed in this category, including stable isotope labelled standards such as Etretinate-d3, are essential for rigorous analytical testing and quality control processes. Pharmaceutical laboratories rely on these high-quality reference standards to perform accurate impurity profiling and to validate analytical methods for both the active pharmaceutical ingredient and its metabolic derivatives. By serving as internal standards in mass spectrometry and chromatographic assays, these compounds enable precise quantification and the detection of trace-level impurities. Utilizing these certified materials ensures compliance with regulatory standards, supports stability studies, and facilitates comprehensive drug development and metabolic research within the pharmaceutical industry.